Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 70 Neoplasms 47 Carcinoma, Non-Small-Cell Lung 26 Colorectal Neoplasms 20 Neoplasm Metastasis 15 Multiple Myeloma 14 Thyroid Neoplasms 12 Glioma 12 Pancreatic Neoplasms 11 Hematologic Neoplasms 10 Thyroid Carcinoma, Anaplastic 9 Brain Neoplasms 8 Lung Neoplasms 7 Triple Negative Breast Neoplasms 5 Rectal Neoplasms 5 Neurofibromatosis 1 5 Lymphoma 5 Leukemia, Myeloid, Acute 5 Colonic Neoplasms 5 Breast Neoplasms 5 Astrocytoma 5 Thyroid Cancer, Papillary 4 Prostatic Neoplasms 4 Neurofibroma, Plexiform 4 Glioblastoma 4 Cholangiocarcinoma 4 Biliary Tract Neoplasms 4 Uveal Melanoma 3 Skin Neoplasms 3 Recurrence 3

Interventions

Carboplatin 9 Pemetrexed 7 osimertinib 5 pembrolizumab 3 entinostat 3 durvalumab 3 Radiosurgery 3 Cisplatin 3 Bevacizumab 3 selpercatinib 2 camrelizumab 2 Paclitaxel 2 Gemcitabine 2 Erlotinib Hydrochloride 2 Docetaxel 2 trametinib 1 sotorasib 1 repotrectinib 1 pralsetinib 1 patritumab 1 nazartinib 1 napabucasin 1 icotinib 1 exemestane 1 cobimetinib 1 ceralasertib 1 cemiplimab 1 capmatinib 1 atezolizumab 1 alectinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Bronchial Neoplasms × trametinib × Clear all

NCT03516214 2024-02-15

EATON

University of Cologne

Phase 1 Completed

Bronchial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡